The valuation of virtual assets held by domestic cryptocurrency exchanges Upbit and Bithumb decreased by 30-40% by the end of the first half of this year. According to the Financial Supervisory Service's electronic disclosure, Dunamu's valuation of its own virtual assets is 1.38 trillion KRW, down 39.6% from the end of last year. Bithumb's valuation is approximately 194.1 billion KRW, a decrease of 30.5%. The value of virtual assets held by the two exchanges has shrunk by about one-third over the past six months. The virtual assets held by the exchanges differ from customer deposit assets and include Bitcoin (BTC), Ethereum (ETH), Ripple (XRP), and Tether (USDT). When market prices fall, the book value decreases, which may be reflected as impairment losses in the income statement. Dunamu operates Upbit, while Bithumb is considered a major exchange. The business structures of both companies are sensitive to trading volumes and the flow of virtual asset prices. Dunamu's directly held virtual assets are recorded as 14,505 BTC, 12,327 ETH, and 11,554,754 USDT. Bithumb's holdings include 294 BTC, 3,138 ETH, and 60,869,264 USDT. The decrease in valuation does not indicate a reduction in customer deposit assets, as customer entrusted assets reflect the quantity and price changes of what users have deposited. The impact on the exchanges' performance should be assessed through the income statement items in the semi-annual report and the flow of virtual asset prices in the second half of the year.
This content is provided for general informational purposes only and doesn't constitute financial, investment, legal, or tax advice. Any events, rewards, online promotions, or related information mentioned herein should not be considered a recommendation, solicitation, or invitation to purchase, sell, trade, or otherwise deal in any crypto assets. Crypto assets are highly volatile and may result in loss. The availability of WEEX services, products, and related events may vary by region. You are responsible for ensuring that your participation is in accordance with applicable local laws and regulations.











Moderna shares more than doubled on 19 August 2026 after Merck and Moderna said the Phase 3 INTerpath-001 trial of intismeran autogene plus KEYTRUDA met its recurrence-free survival endpoint in resected melanoma. This page explains what the result is, why the stock reacted this hard, what is still unknown, which dates come next (presentation and earnings, both unconfirmed), and what a trader can actually do on WEEX — which does not list Moderna; the nearest instrument is the XBI-USDT biotech ETF perpetual. No price targets, no forecasts.















Long-end U.S. Treasury yields surged to multi-year highs, pressuring technology, semiconductor, storage, and optical communication stocks and driving a clear cooling in market risk appetite. At the same time, Anthropic’s revenue came in below some bullish expectations, prompting investors to reassess the AI growth narrative; Unitree Robotics officially listed on the STAR Market, extending momentum in robotics and embodied AI; while SpaceX and other commercial space names showed relative resilience. Investors are now focused on tonight’s Federal Reserve minutes for clearer signals on the policy path and broader market sentiment.



